557 related articles for article (PubMed ID: 24907175)
41. Metabolic and body composition changes after six months of highly active antiretroviral therapy in northern Indian patients.
Gupta V; Biswas A; Sharma SK
Int J STD AIDS; 2011 Jan; 22(1):46-9. PubMed ID: 21364067
[TBL] [Abstract][Full Text] [Related]
42. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
[TBL] [Abstract][Full Text] [Related]
43. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
44. Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls.
Bergersen BM; Schumacher A; Sandvik L; Bruun JN; Birkeland K
Scand J Infect Dis; 2006; 38(8):682-9. PubMed ID: 16857615
[TBL] [Abstract][Full Text] [Related]
45. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.
Indhavivadhana S; Wongwananuruk T; Rattanachaiyanont M; Techatraisak K; Leerasiri P; Tanmahasamut P; Popijan M
J Med Assoc Thai; 2010 Jun; 93(6):653-60. PubMed ID: 20572369
[TBL] [Abstract][Full Text] [Related]
47. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
48. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.
Badiou S; Thiebaut R; Aurillac-Lavignolle V; Dabis F; Laporte F; Cristol JP; Mercie P;
J Infect; 2008 Jul; 57(1):47-54. PubMed ID: 18554723
[TBL] [Abstract][Full Text] [Related]
49. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.
Floris-Moore M; Howard AA; Lo Y; Arnsten JH; Santoro N; Schoenbaum EE
HIV Med; 2006 Oct; 7(7):421-30. PubMed ID: 16925727
[TBL] [Abstract][Full Text] [Related]
50. Lipodystrophy and dyslipidemia in human immunodeficiency virus-infected Thai patients receiving antiretroviral therapy.
Chuapai Y; Kiertiburanakul S; Malathum K; Sungkanuparph S
J Med Assoc Thai; 2007 Mar; 90(3):452-8. PubMed ID: 17427520
[TBL] [Abstract][Full Text] [Related]
51. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
52. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.
Mondy K; Overton ET; Grubb J; Tong S; Seyfried W; Powderly W; Yarasheski K
Clin Infect Dis; 2007 Mar; 44(5):726-34. PubMed ID: 17278068
[TBL] [Abstract][Full Text] [Related]
53. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
[TBL] [Abstract][Full Text] [Related]
54. Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment.
Ekali LG; Johnstone LK; Echouffo-Tcheugui JB; Kouanfack C; Dehayem MY; Fezeu L; Nouthe B; Hayes L; Unwin NC; Sobngwi E
Diabetes Metab; 2013 Feb; 39(1):71-7. PubMed ID: 23153435
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
[TBL] [Abstract][Full Text] [Related]
56. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia.
Tadewos A; Egeno T; Amsalu A
BMC Cardiovasc Disord; 2017 Aug; 17(1):218. PubMed ID: 28789613
[TBL] [Abstract][Full Text] [Related]
57. Dyslipidemia among rural and urban HIV patients in south-east Malawi.
Amberbir A; Singano V; Matengeni A; Ismail Z; Kawalazira G; Chan AK; Sodhi SD; van Oosterhout JJ
PLoS One; 2018; 13(5):e0197728. PubMed ID: 29782548
[TBL] [Abstract][Full Text] [Related]
58. Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.
Mekuria Y; Yilma D; Mekonnen Z; Kassa T; Gedefaw L
PLoS One; 2016; 11(8):e0161180. PubMed ID: 27537338
[TBL] [Abstract][Full Text] [Related]
59. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.
Dave JA; Levitt NS; Ross IL; Lacerda M; Maartens G; Blom D
PLoS One; 2016; 11(3):e0151911. PubMed ID: 26986065
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of metabolic syndrome among HIV-infected patients in Ghana: A cross-sectional study.
Obirikorang C; Quaye L; Osei-Yeboah J; Odame EA; Asare I
Niger Med J; 2016; 57(2):86-90. PubMed ID: 27226681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
